Proton pump inhibitor therapy does not increase the incidence of spontaneous bacterial peritonitis in cirrhosis: A multicenter prospective study-Reference-Cited by-同舟云学术

Proton pump inhibitor therapy does not increase the incidence of spontaneous bacterial peritonitis in cirrhosis: A multicenter prospective study

Published:2015-05 Issue:5 Volume:62 Page:1056-1060
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Terg Rubén,Casciato Paola,Garbe Cecilia,Cartier Mariano,Stieben Teodoro,Mendizabal Manuel,Niveyro Carla,Benavides Javier,Marino Mónica,Colombato Luis,Berbara Daniel,Silva Marcelo,Salgado Pablo,Barreyro Fernando,Fassio Eduardo,Gadano Adrian

Publisher

Elsevier BV

Subject

Hepatology

Reference26 articles.

1. Pallarito K. How safe are popular reflux drugs? Experts debate evidence–linking acid-blockers to possible bone, heart problems. US News World Rep; 2009.

2. Proton pump inhibitor use, hip fracture and change in bone mineral density in postmenopausal women: results from the Women’s Health Initiative;Gray;Arch Intern Med,2010

3. Gastric acid suppression by proton pump inhibitors as a risk factor for Clostridium difficile associated diarrhea in hospitalized patients;Asseri;Am J Gastroenterol,2008

4. Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs;Laheij;JAMA,2004

5. Association between proton pump inhibitors use and spontaneous bacterial peritonitis;Campbell;Dig Dis Sci,2008

Cited by 109 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Proton Pump Inhibitors in Patients with Cirrhosis: Pharmacokinetics, Benefits and Drawbacks;Current Gastroenterology Reports;2024-08-21

2. Editorial: Novel insights into the prognostic relevance of high‐dose PPI treatment in patients with cirrhosis;Alimentary Pharmacology & Therapeutics;2024-04-23

3. High‐dose proton pump inhibitor treatment is associated with a higher mortality in cirrhotic patients: A multicentre study;Alimentary Pharmacology & Therapeutics;2024-02-22

4. Proton Pump Inhibitors Increases Longitudinal Risk of Mortality, Decompensation, and Infection in Cirrhosis: A Meta-Analysis;Digestive Diseases and Sciences;2023-11-15

5. Risks of Proton Pump Inhibitors in Patients with Cirrhosis: Please Peruse the Indications;Digestive Diseases and Sciences;2023-11-15